Japan Revises the Requirements for Quasi-drugs

On March 27, 2023, MHLW issued Notification 0327 No. 1 and Notification 0327 No. 5, including minor adjustments to reagents and test solutions in Japanese Standards of Quasi-drug Ingredients 2021 (hereinafter the "JSQI 2021") and revision to the application for manufacturing and sales license. These amendments came into effect upon its publication on March 27, but the previous provisions can still be applied before September 30, 2024.